Skip to main
USPH

USPH Stock Forecast & Price Target

USPH Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 25%
Buy 75%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

US Physical Therapy is expected to experience strong revenue growth in the coming months due to the implementation of two announced hospital partnerships and the potential for additional health system partnerships. Furthermore, with operating expenses expected to improve by 180-bps and other expenses anticipated to be 20.8% of revenue, the company's profitability and financial performance are expected to improve significantly. Additionally, the impact of Medicaid rate pressure is relatively minimal, further supporting a positive outlook on the company's stock.

Bears say

US Physical Therapy is currently trading at 10.7x its 2026 EBITDA estimate, lower than its average of 15x since mid-2023. However, the analyst remains constructive on the company due to potential growth from improved Medicare rates, accretive M&A, and the company's new hospital channel strategy. With a trough valuation and a double-digit profit growth profile, the risk-reward profile is seen as asymmetric, leading the analyst to remain positive on USPH despite recent sector multiple compression.

USPH has been analyzed by 4 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 75% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of U.S. Physical Therapy and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About U.S. Physical Therapy (USPH) Forecast

Analysts have given USPH a Buy based on their latest research and market trends.

According to 4 analysts, USPH has a Buy consensus rating as of May 12, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $100.75, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $100.75, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

U.S. Physical Therapy (USPH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.